Triple-negative breast most cancers (TNBC) is essentially the most invasive breast most cancers missing progesterone receptor (PR), estrogen receptor (ER), and human epidermal progress issue receptor 2 (HER2), and accounting for about 15–20% of the breast most cancers circumstances worldwide [1], [2], [3]. A number of therapeutic approaches together with chemotherapy, phototherapy, and immunotherapy have been tried for treating TNBC [4], [5], [6]. However, as a result of weak immunogenicity of TNBC, restricted T cell infiltration, and the considerable immunosuppressive cells in tumor microenvironment (TME), the therapeutic inhibition of TNBC development and metastasis is commonly compromised [7], [8], [9]. In addition to, the dearth of tumor targetability and the event of drug resistance can additional weaken the therapeutic efficacy of TNBC therapy [10], [11], [12], [13]. Due to this fact, modern methods able to transforming the TME from an immunologically “chilly” to a “scorching” state are urgently required to enhance the therapeutic outcomes in TNBC.
One distinguished strategy for enhancing tumor immunity to transform TME in opposition to TNBC is immunogenic cell loss of life (ICD), which may be triggered after varied therapeutic modalities reminiscent of light-based remedy, chemotherapy, and radiotherapy to synergistically enhance the therapeutic outcomes [14], [15], [16], [17]. Amongst them, photodynamic remedy (PDT) is a typical light-based therapeutic technique and has attracted appreciable consideration resulting from its wonderful spatiotemporal selectivity and minimal invasiveness. PDT generates reactive oxygen species (ROS) to induce tumor cell apoptosis and necrosis, resulting in the discharge of tumor-associated antigens (TAAs) and cytosolic elements from dying tumor cells that additional provoke ICD, finally selling immune activation and TME transforming [18], [19], [20], [21], [22]. Violet phosphorus (VP) was initially found from molten lead by Hittorf in 1865, but systematic investigations into its preparation and physicochemical traits of VP have solely emerged over the previous decade. VP is essentially the most steady phosphorus allotrope that may be synthesized by means of chemical vapor transport (CVT) methodology. Not too long ago, VP nanosheet (VPN) has been efficiently ready from bulk VP based mostly on liquid-phase exfoliation methodology [23], [24]. Notably, VPN has been reported to exhibit pronounced photodynamic results beneath laser irradiation, highlighting its potential as a promising photosensitizer for most cancers remedy by means of PDT and PDT-induced immune activation for TME transforming [25]. In the meantime, the excessive biosafety of VPN additional helps its feasibility for biomedical functions [26].
Immune checkpoint blockade remedy (ICBT), one of the vital breakthroughs in most cancers immunotherapy, was acknowledged with the Nobel Prize in Physiology or Medication in 2018 [27]. Among the many quite a few immune checkpoint pathways, each PD-1 and its major ligand PD-L1 play important roles in regulating immune responses throughout most cancers immunotherapy [28], [29]. The PD-L1 expressed on tumor cells may be additional upregulated after anticancer therapies, resulting in immune evasion and the institution of an immunosuppressive TME by means of the interplay with the PD-1 on varied immunocytes [30], [31], [32]. Due to this fact, blocking the interplay of PD-1 to PD-L1 based mostly on ICBT is pivotal to beat immunosuppression and transform the TME [33], [34], [35]. At current, the blockade of PD-1/PD-L1 signaling pathway in scientific ICBT is primarily achieved utilizing antibody-based therapies focusing on PD-1 or PD-L1 [36], [37], [38], [39], [40], [41]. However, as a result of low immunogenicity of most tumors, the responsivity to ICBT in clinic stays under 30%. Furthermore, though ICBT alone exhibits potential for inhibiting metastasis, its therapeutic impact in opposition to stable tumors remains to be restricted [42], [43], [44].
In mild of this, herein, VPN was innovatively utilized because the photosensitive nano-drug platform to co-load methylene blue (MB) and doxorubicin (DOX) after electrostatic interplay for TNBC therapy. Subsequently, the three-in-one MB- and DOX-loaded VP nanocomposite (MDV) along with anti-PD-L1 antibody (aPD-L1) had been co-incorporated into polymetformin (PM)-based hydrogel platform (PM gel) to kind an immunogel (MDVa@PM gel), which successfully reworked the TME from an immunologically “chilly” to “scorching” state and inhibited TNBC development and metastasis. Particularly, on this ready immunogel, the integrated VPN confirmed a number of benefits together with photodynamic impact, excessive drug-loading functionality, and wonderful biocompatibility. The electrostatic loading of MB and DOX onto VPN not solely enhanced each PDT and PDT-induced tumor immune activation beneath 660 nm laser irradiation, but additionally synergized with chemotherapy and MB-mediated PD-1 inhibition. Furthermore, typical hydrogel platforms typically undergo from a number of limitations reminiscent of poor stability, inadequate drug launch, and the dearth of injectability, biodegradability, and intrinsic antitumor exercise [45], [46]. To handle these limitations, we developed a multifunctional hydrogel platform (PM gel) fashioned by means of Schiff base response between PM and the crosslinker dibenzaldehyde-functionalized PEG 2000 (DF-PEG). PM, a cationic polymer that inherits the distinctive properties of metformin (Met) as a result of considerable biguanide teams grafted onto its polymer chain, thereby exhibiting intrinsic tumor-inhibitory and TME transforming capabilities by means of activating AMPK and inhibiting mTOR signaling pathways [47], [48], [49]. As well as, the dynamicity and weak-acid sensitivity of the Schiff base bonds in PM gel enabled gel–sol transition upon structural disruption beneath exterior shearing drive or in acidic atmosphere. This property allowed PM gel to be injectable and degradable throughout the weakly acidic TME after intratumoral administration, whereas sustaining structural stability beneath physiological pH with out exterior shearing drive. Consequently, PM gel offered a multifunctional platform able to TME transforming, direct anti-TNBC impact, and managed drug launch. Moreover, aPD-L1 was co-encapsulated into PM gel along with MDV to dam the PDT-induced upregulation of PD-L1 at tumor web site, which additional reworked TME and successfully suppressed tumor metastasis. General, this immunogel system mixed with PDT not solely inhibited the development of major and abscopal tumors, but additionally established long-term immune reminiscence to stop metastasis, providing a promising technique for TME transforming by means of reinforcing immunotherapy for TNBC therapy with potential analysis and scientific worth (Scheme 1).
